Corient Private Wealth LLC Has $47.26 Million Stock Position in Veeva Systems Inc. $VEEV

Corient Private Wealth LLC lessened its stake in shares of Veeva Systems Inc. (NYSE:VEEV) by 3.3% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 164,111 shares of the technology company’s stock after selling 5,526 shares during the period. Corient Private Wealth LLC owned about 0.10% of Veeva Systems worth $47,261,000 at the end of the most recent reporting period.

Several other institutional investors have also made changes to their positions in the company. Sigma Planning Corp lifted its position in shares of Veeva Systems by 1.2% in the 2nd quarter. Sigma Planning Corp now owns 3,328 shares of the technology company’s stock valued at $958,000 after acquiring an additional 39 shares in the last quarter. Keybank National Association OH lifted its holdings in shares of Veeva Systems by 1.4% in the second quarter. Keybank National Association OH now owns 3,088 shares of the technology company’s stock valued at $889,000 after purchasing an additional 42 shares in the last quarter. Facet Wealth Inc. boosted its position in shares of Veeva Systems by 3.3% in the second quarter. Facet Wealth Inc. now owns 1,342 shares of the technology company’s stock worth $381,000 after buying an additional 43 shares during the period. TFB Advisors LLC grew its holdings in shares of Veeva Systems by 1.2% during the first quarter. TFB Advisors LLC now owns 3,586 shares of the technology company’s stock valued at $831,000 after buying an additional 44 shares in the last quarter. Finally, Triangle Securities Wealth Management raised its position in Veeva Systems by 0.8% during the second quarter. Triangle Securities Wealth Management now owns 5,782 shares of the technology company’s stock valued at $1,665,000 after buying an additional 45 shares during the period. 88.20% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on the company. Morgan Stanley raised their price objective on Veeva Systems from $210.00 to $222.00 and gave the stock an “underweight” rating in a research report on Thursday, August 28th. JPMorgan Chase & Co. raised shares of Veeva Systems from a “neutral” rating to an “overweight” rating and boosted their price objective for the company from $290.00 to $330.00 in a research report on Monday, September 8th. Jefferies Financial Group reiterated a “buy” rating and issued a $330.00 price objective on shares of Veeva Systems in a research note on Monday, November 24th. BTIG Research reissued a “buy” rating and set a $340.00 target price on shares of Veeva Systems in a research note on Friday, November 21st. Finally, Oppenheimer restated an “outperform” rating and set a $325.00 price target on shares of Veeva Systems in a report on Thursday, August 28th. Eighteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, Veeva Systems has a consensus rating of “Moderate Buy” and a consensus price target of $307.42.

Veeva Systems Stock Down 0.4%

Shares of VEEV opened at $219.24 on Wednesday. The firm has a market cap of $36.04 billion, a price-to-earnings ratio of 42.65, a price-to-earnings-growth ratio of 1.63 and a beta of 1.05. The company’s fifty day moving average is $270.11 and its 200-day moving average is $278.16. Veeva Systems Inc. has a 12 month low of $201.54 and a 12 month high of $310.50.

Veeva Systems (NYSE:VEEV) last released its quarterly earnings data on Thursday, November 20th. The technology company reported $2.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.95 by $0.09. The business had revenue of $0.81 million during the quarter, compared to analyst estimates of $792.37 million. Veeva Systems had a net margin of 27.93% and a return on equity of 13.68%. Veeva Systems’s quarterly revenue was up 16.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.75 EPS. Veeva Systems has set its FY 2026 guidance at 7.930-7.93 EPS and its Q4 2026 guidance at 1.920-1.920 EPS. As a group, research analysts predict that Veeva Systems Inc. will post 4.35 earnings per share for the current fiscal year.

Insider Activity

In other Veeva Systems news, insider Thomas D. Schwenger sold 3,350 shares of the stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $300.04, for a total transaction of $1,005,134.00. Following the transaction, the insider owned 23,773 shares in the company, valued at $7,132,850.92. This trade represents a 12.35% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Eleni Nitsa Zuppas sold 6,000 shares of the business’s stock in a transaction on Tuesday, October 7th. The stock was sold at an average price of $306.62, for a total transaction of $1,839,720.00. Following the completion of the sale, the insider owned 25,325 shares of the company’s stock, valued at $7,765,151.50. The trade was a 19.15% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 24,665 shares of company stock valued at $7,438,000. Insiders own 10.30% of the company’s stock.

Veeva Systems Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.